Filtered By:
Condition: Ischemic Stroke
Management: Insurance

This page shows you your search results in order of date. This is page number 19.

Order by Relevance | Date

Total 850 results found since Jan 2013.

A Retrospective Population-Based Survival Study of Idiopathic Pulmonary Arterial Hypertension in Korea
CONCLUSION: The 10-year SR of IPAH was 57% in Korea. The HR for IPAH was significantly high in patients with older age and other risk factors.PMID:35289139 | PMC:PMC8921213 | DOI:10.3346/jkms.2022.37.e80
Source: Journal of Korean Medical Science - March 15, 2022 Category: Biomedical Science Authors: Shin Yi Jang Eun Kyoung Kim June Huh Jinyoung Song I-Seok Kang Seung Woo Park Duk-Kyung Kim Sung-A Chang Source Type: research

IJERPH, Vol. 19, Pages 3050: Sex and Economic Disparity Related to Reperfusion Therapies for Patients with Acute Ischemic Stroke in South Korea across a 10-Year Period: A Nationwide Population-Based Study Using the National Health Insurance Database
This study included AIS patients aged ≥20 years who were hospitalized in a general hospital or tertiary hospital for ≥4 days and underwent brain imaging during the same period. Study participants were classified by sex, economic status (Medical Aid beneficiaries and National Health Insurance beneficiaries) and age (20–44, 45–64, 65–79, and ≥80 years). Women showed a significantly lower OR (Odds ratio) than men in IVT (OR: 0.75; 95% CI: 0.73–0.77), EVT (OR: 0.96; 95% CI: 0.93–0.99), and any therapy (OR: 0.82; 95% CI: 0.80&...
Source: International Journal of Environmental Research and Public Health - March 5, 2022 Category: Environmental Health Authors: Jusun Moon Jinyoung Shin Jeehye Lee Ho Jin Jeong Hyeongsu Kim Jaehyeong An Sung Hyun Jo Kwang-Pil Ko Jeoungbin Choi Tags: Article Source Type: research

Effect Modification by Indication to the Risks of Major Thromboembolic Adverse Events in Patients Receiving Intravitreal Anti-Vascular Endothelial Growth Factor Treatment: A Population-Based Retrospective Cohort Study
ConclusionsPatients treated with aflibercept or ranibizumab for different indications may be associated with varying risk of TAEs. The findings provide evidence to support treatment selection, taking indications and TAE risk into consideration.
Source: BioDrugs - March 1, 2022 Category: Drugs & Pharmacology Source Type: research

New-Onset Atrial Fibrillation Is a Risk Factor of Ischemic Stroke in Chronic Obstructive Pulmonary Disease
In conclusion, COPD patients suffering from new-onset AF had an increased incidence of IS in the population observation study. New-onset AF was an omit risk factor for IS in COPD in the Chinese population.PMID:35206997 | DOI:10.3390/healthcare10020381
Source: Atherosclerosis - February 25, 2022 Category: Cardiology Authors: Chi-Chun Liu Yu-Hsuan Chen Yin-Han Chang Wu-Chien Chien Hui-Chen Lin Chun-Gu Cheng Chun-An Cheng Source Type: research

Hypertension in the South African public healthcare system: a cost-of-illness and burden of disease study
Conclusion Hypertension exerts a heavy health and economic burden on South Africa. Establishing cost-effective best practice guidelines for hypertension treatment requires further research. Such research will be essential if South Africa is to make progress in its efforts to implement universal healthcare.
Source: BMJ Open - February 22, 2022 Category: General Medicine Authors: Kohli-Lynch, C. N., Erzse, A., Rayner, B., Hofman, K. J. Tags: Open access, Health economics Source Type: research

Predicting Hospital Readmissions from Health Insurance Claims Data: A Modeling Study Targeting Potentially Inappropriate Prescribing
CONCLUSION: PIP successfully predicted readmissions for most diseases, opening the possibility for interventions to improve these modifiable risk factors. Machine-learning methods appear promising for future modeling of PIP predictors in complex older patients with many underlying diseases.PMID:35144291 | DOI:10.1055/s-0042-1742671
Source: Methods of Information in Medicine - February 10, 2022 Category: Information Technology Authors: Alexander Gerharz Carmen Ruff Lucas Wirbka Felicitas Stoll Walter E Haefeli Andreas Groll Andreas D Meid Source Type: research

Effect of total cholesterol level variabilities on cerebrovascular disease
CONCLUSIONS: Our study shows that cholesterol changes, especially larger changes, lead to an increase in CVD, which demonstrates that cholesterol variability may increase CVD.PMID:35113431 | DOI:10.26355/eurrev_202201_27882
Source: European Review for Medical and Pharmacological Sciences - February 3, 2022 Category: Drugs & Pharmacology Authors: Y Bae J Heo Y Chung S-Y Shin S W Lee Source Type: research